Related references
Note: Only part of the references are listed.Does DPP-IV Inhibition Offer New Avenues for Therapeutic Intervention in Malignant Disease?
Petr Busek et al.
CANCERS (2022)
Angiogenesis is promoted by exosomal DPP4 derived from 5-fluorouracil-resistant colon cancer cells
Xixi Zheng et al.
CANCER LETTERS (2021)
CD26 as a Promising Biomarker for Predicting Prognosis in Patients with Pancreatic Tumors
Liang Yan et al.
ONCOTARGETS AND THERAPY (2020)
A novel role for CD26/dipeptidyl peptidase IV as a therapeutic target
Kei Ohnuma et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2018)
Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2015
Kyu-Won Jung et al.
CANCER RESEARCH AND TREATMENT (2018)
The promotion of the transformation of quiescent gastric cancer stem cells by IL-17 and the underlying mechanisms
Y-X Jiang et al.
ONCOGENE (2017)
DPP4/CD26 overexpression in urothelial carcinoma confers an independent prognostic impact and correlates with intrinsic biological aggressiveness
Peir-In Liang et al.
ONCOTARGET (2017)
Dipeptidyl Peptidase IV as a Prognostic Marker and Therapeutic Target in Papillary Thyroid Carcinoma
Jie-Jen Lee et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2017)
Incretin-based pharmacotherapy and risk of adverse pancreatic events in the ethnic Chinese with diabetes mellitus: A population-based study in Taiwan
Chao-Ming Tseng et al.
PANCREATOLOGY (2017)
Survival analysis based on human epidermal growth factor 2 status in stage II-III gastric cancer
Jang Ho Cho et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2017)
Regulation and roles of CD26/DPPIV in hematopoiesis and diseases
Zeynab Aliyari Serej et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
Serum HER2 as an adjunct to assess HER2 status for advanced gastric cancer: A prospective multicenter trial (SHERLOCK)
Mayuko Saito et al.
ACTA ONCOLOGICA (2016)
Cut to the chase: a review of CD26/dipeptidyl peptidase-4's (DPP4) entanglement in the immune system
C. Klemann et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2016)
Serum CD26 levels in patients with gastric cancer: a novel potential diagnostic marker
Virginia Boccardi et al.
BMC CANCER (2015)
Surgically resected human tumors reveal the biological significance of the gastric cancer stem cell markers CD44 and CD26
Shimpei Nishikawa et al.
ONCOLOGY LETTERS (2015)
Postoperative Serum Levels of sCD26 for Surveillance in Colorectal Cancer Patients
Loretta De Chiara et al.
PLOS ONE (2014)
The ErbB/HER family of protein-tyrosine kinases and cancer
Robert Roskoski
PHARMACOLOGICAL RESEARCH (2014)
CD26 Overexpression Is Associated with Prolonged Survival and Enhanced Chemosensitivity in Malignant Pleural Mesothelioma
Keisuke Aoe et al.
CLINICAL CANCER RESEARCH (2012)
Surveillance Strategy of Atrophic Gastritis and Intestinal Metaplasia in a Country with a High Prevalence of Gastric Cancer
Woon Geon Shin et al.
DIGESTIVE DISEASES AND SCIENCES (2012)
Advances in the Management of HER2-positive Advanced Gastric and Gastroesophageal Junction Cancer
Yung-Jue Bang
JOURNAL OF CLINICAL GASTROENTEROLOGY (2012)
Effect of endoscopic screening at 1-year intervals on the clinicopathologic characteristics and treatment of gastric cancer in South Korea
Hyuk Yoon et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2012)
Evaluation of the 7th UICC TNM Staging System of Gastric Cancer
Sung Joon Kwon
JOURNAL OF GASTRIC CANCER (2011)
Serum CD26 is related to histopathological polyp traits and behaves as a marker for colorectal cancer and advanced adenomas
Loretta De Chiara et al.
BMC CANCER (2010)
A Subpopulation of CD26+ Cancer Stem Cells with Metastatic Capacity in Human Colorectal Cancer
Roberta Pang et al.
CELL STEM CELL (2010)
Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
Yung-Jue Bang et al.
LANCET (2010)
HER2 diagnostics in gastric cancer-guideline validation and development of standardized immunohistochemical testing
Josef Rueschoff et al.
VIRCHOWS ARCHIV (2010)
Role of CD26/dipeptidyl peptidase IV in human T cell activation and function
Kei Ohnuma et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2008)
Assessment of a HER2 scoring system for gastric cancer:: results from a validation study
M. Hofmann et al.
HISTOPATHOLOGY (2008)
Preoperative serum CD26 levels:: diagnostic efficiency and predictive value for colorectal cancer
OJ Cordero et al.
BRITISH JOURNAL OF CANCER (2000)
Share Paper
